Cargando…
Are Circulating Cytokines Reliable Biomarkers for Amyotrophic Lateral Sclerosis?
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that has no effective treatment. The lack of any specific biomarker that can help in the diagnosis or prognosis of ALS has made the identification of biomarkers an urgent challenge. Multiple panels have shown alterations in lev...
Autores principales: | Moreno-Martinez, Laura, Calvo, Ana Cristina, Muñoz, María Jesús, Osta, Rosario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600567/ https://www.ncbi.nlm.nih.gov/pubmed/31195629 http://dx.doi.org/10.3390/ijms20112759 |
Ejemplares similares
-
Circulating Cytokines Could Not Be Good Prognostic Biomarkers in a Mouse Model of Amyotrophic Lateral Sclerosis
por: Moreno-Martínez, Laura, et al.
Publicado: (2019) -
Lessons to Learn from the Gut Microbiota: A Focus on Amyotrophic Lateral Sclerosis
por: Calvo, Ana Cristina, et al.
Publicado: (2022) -
Amyotrophic Lateral Sclerosis: A Focus on Disease Progression
por: Calvo, Ana C., et al.
Publicado: (2014) -
Comparative study of behavioural tests in the SOD1G93A mouse model of
amyotrophic lateral sclerosis
por: OLIVÁN, Sara, et al.
Publicado: (2014) -
MicroRNA-206: A Potential Circulating Biomarker Candidate for Amyotrophic Lateral Sclerosis
por: Toivonen, Janne M., et al.
Publicado: (2014)